Frank Rimerman Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Frank Rimerman Advisors's BIIB Position: Q2 2026 in Review
Frank Rimerman Advisors increased its Biogen (BIIB) stake by 0.06% in Q2 2026, buying an estimated $574 and bringing the position to 5,197 shares worth $1.12M. The position accounts for 0.06% of the portfolio, ranked #225.
Frank Rimerman Advisors first reported a position in BIIB in Q4 2023 and has held it in 8 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Frank Rimerman Advisors held 5,197 shares of Biogen worth $1.12M as of Q2 2026.
- Frank Rimerman Advisors bought 3 Biogen shares in Q2 2026, an estimated $574.
- Biogen made up 0.06% of Frank Rimerman Advisors's portfolio in Q2 2026, its #225 holding.
- Frank Rimerman Advisors first reported a position in Biogen in Q4 2023 and has held it in 8 quarters since.
- 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Frank Rimerman Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.